[Congressional Record Volume 167, Number 212 (Wednesday, December 8, 2021)]
[Senate]
[Page S9045]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                         REPORTS OF COMMITTEES

  The following reports of committees were submitted:

       By Mr. DURBIN, from the Committee on the Judiciary, without 
     amendment:
       S. 1425. A bill to enable the Federal Trade Commission to 
     deter filing of sham citizen petitions to cover an attempt to 
     interfere with approval of a competing generic drug or 
     biosimilar, to foster competition, and facilitate the 
     efficient review of petitions filed in good faith to raise 
     legitimate public health concerns, and for other purposes.

                          ____________________